G1 Therapeutics, Inc. (GTHX) Tops Q1 EPS by 11c

G1 Therapeutics, Inc. (NASDAQ: GTHX) reported Q1 EPS of ($0.53), $0.11 better than the analyst estimate of ($0.64). Revenue for the quarter came in at $12.95 million versus the consensus estimate of $11.17 million.

For earnings history and earnings-related data on G1 Therapeutics, Inc. (GTHX) click here.

You May Also Be Interested In

• Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
• DA Davidson Assumes Knife River Corp. (KNF) at Buy
• BXP Inc. (BXP) PT Raised to $70 at UBS as Earnings Outlook Accelerates